Advancing medicines
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. Our team asks questions and identifies opportunities others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. Our initial focus, supported by our current approved products and late stage pipeline, is to address immediate CNS challenges.
Our success is proven
2
Billion PharmFilm doses consumed by patients
200+
Worldwide patents
4
Continents where our products are sold
Latest news
-
Aquestive Therapeutics, Inc. commends Sunovion Pharmaceuticals Inc.
Aquestive Therapeutics, Inc. commends Sunovion Pharmaceuticals Inc., our partner in the development of oral films containing apomorphine, on the submission of their new drug application (NDA) to the U...
-
Aquestive Therapeutics Receives U.S. FDA Orphan Drug Designation for Riluzole Oral Soluble Film to Treat ALS
WARREN, N.J., January 31, 2018 – Aquestive Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Riluzole Oral Soluble Film (ril...
